Digital solutions for haemophilia – a bright future ahead

Tuesday 9 May 2023

florio HEAMO is joining forces with smart medication ediary to further strengthen and develop new innovative digital solutions for people with haemophilia and their care teams. Established features of the two leading platforms will be combined into a new/evolved version of florio HEAMO to support patients and healthcare professionals. This exciting collaboration was announced at the congress of the Society of Thrombosis and Haemastasiology (GTH) in February 2023 in Frankfurt and was welcomed by healthcare professionals in the haemophilia arena.

Strong partners – Together for a bright future

florio HAEMO is an innovative digital medical device developed by Florio GmbH to support people with haemophilia and their care teams. florio HAEMO was developed in close partnership with patients and healthcare professionals and was launched in 2020 and is now available in more than 20 countries. Its unique and user-centric design was acknowledged with the iF design award.

Based on an original research project from Phillips-University in Marburg, smart medication ediary started in 2010 as an independent electronic diary for people with haemophilia in Germany and Switzerland. Aiming to connect patients and their healthcare teams it was then developed into one of the first digital medical device apps in Germany with established interfaces and links to, hospitals and pharmacies as well as the German haemophilia registry.

Florio and smart medication have now agreed to join forces and develop a combined innovative platform for the future of haemophilia.

Leadership update

In line with these recent developments and additional product launches, Katharina Steinitz-Trost moved to Florio GmbH as CEO/Managing Director committed to bring new innovative solutions to patients with rare diseases and their care teams.